Bio-Path Holdings Announces the Appointment of William Hahne as Vice President of Clinical Development
April 17, 2017 at 05:30 pm IST
Bio-Path Holdings, Inc. announced the appointment of William Hahne, MD, to the newly created position of vice president of clinical research. Before joining Bio-Path, Dr. Hahne was a medical consultant for a number of organizations including Voisin consulting, Medimmune, Lion Biotechnologies, Seattle Genetics, Aminex Therapeutics, Therakos, and Celgene Cellular Therapeutics.